Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stillbirth | 3 | 2023 | 369 | 1.390 |
Why?
|
| Pharmacoepidemiology | 2 | 2023 | 351 | 0.810 |
Why?
|
| Azathioprine | 1 | 2020 | 354 | 0.620 |
Why?
|
| Mycophenolic Acid | 1 | 2020 | 350 | 0.590 |
Why?
|
| Pharyngitis | 1 | 2018 | 220 | 0.530 |
Why?
|
| Streptococcus pyogenes | 1 | 2018 | 292 | 0.510 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 533 | 0.480 |
Why?
|
| Teratogens | 3 | 2024 | 117 | 0.480 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2019 | 991 | 0.470 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2024 | 2517 | 0.450 |
Why?
|
| Streptococcal Infections | 1 | 2018 | 617 | 0.440 |
Why?
|
| Medicaid | 3 | 2023 | 2813 | 0.430 |
Why?
|
| Papillomavirus Infections | 3 | 2019 | 1616 | 0.400 |
Why?
|
| Heart Arrest | 2 | 2019 | 1513 | 0.400 |
Why?
|
| Pyrroles | 1 | 2018 | 1124 | 0.400 |
Why?
|
| Research Design | 1 | 2023 | 6180 | 0.290 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4190 | 0.280 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 2019 | 0.280 |
Why?
|
| Pyrimidines | 1 | 2018 | 3027 | 0.260 |
Why?
|
| Hospitals | 1 | 2019 | 3881 | 0.250 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3198 | 0.240 |
Why?
|
| Valproic Acid | 2 | 2024 | 443 | 0.230 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15308 | 0.220 |
Why?
|
| Pregnancy | 10 | 2024 | 29893 | 0.180 |
Why?
|
| Papillomaviridae | 2 | 2017 | 1120 | 0.180 |
Why?
|
| Maternal Age | 1 | 2023 | 809 | 0.170 |
Why?
|
| Live Birth | 1 | 2022 | 511 | 0.160 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2022 | 339 | 0.160 |
Why?
|
| Azithromycin | 1 | 2020 | 199 | 0.160 |
Why?
|
| Chloroquine | 1 | 2020 | 274 | 0.160 |
Why?
|
| Streptococcus | 1 | 2018 | 197 | 0.150 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 2019 | 0.150 |
Why?
|
| International Classification of Diseases | 1 | 2023 | 915 | 0.140 |
Why?
|
| Causality | 1 | 2023 | 1244 | 0.140 |
Why?
|
| Gestational Age | 2 | 2023 | 3580 | 0.140 |
Why?
|
| Age Distribution | 1 | 2023 | 2871 | 0.140 |
Why?
|
| Genotype | 4 | 2022 | 12985 | 0.140 |
Why?
|
| Nutrition Surveys | 3 | 2019 | 1723 | 0.140 |
Why?
|
| Vaginal Douching | 1 | 2016 | 17 | 0.140 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
| Mouth Diseases | 1 | 2017 | 240 | 0.120 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 316 | 0.110 |
Why?
|
| Cough | 1 | 2016 | 594 | 0.100 |
Why?
|
| Community-Acquired Infections | 1 | 2016 | 469 | 0.100 |
Why?
|
| Family | 1 | 2023 | 3192 | 0.100 |
Why?
|
| ROC Curve | 1 | 2019 | 3584 | 0.090 |
Why?
|
| Insurance, Health | 1 | 2023 | 2493 | 0.090 |
Why?
|
| Humans | 22 | 2024 | 761222 | 0.090 |
Why?
|
| Female | 16 | 2024 | 392552 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 2746 | 0.080 |
Why?
|
| Piperidines | 1 | 2018 | 1656 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1663 | 0.080 |
Why?
|
| Epilepsy | 1 | 2024 | 3304 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2023 | 7965 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2020 | 24022 | 0.070 |
Why?
|
| United States | 8 | 2024 | 72341 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2020 | 2795 | 0.070 |
Why?
|
| Risk Factors | 5 | 2020 | 74241 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2024 | 80675 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5333 | 0.060 |
Why?
|
| Young Adult | 6 | 2024 | 59222 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 20118 | 0.060 |
Why?
|
| Hypertension | 1 | 2024 | 8536 | 0.060 |
Why?
|
| Sulfamethoxazole | 1 | 2023 | 51 | 0.060 |
Why?
|
| Adult | 8 | 2024 | 221120 | 0.060 |
Why?
|
| Trimethoprim | 1 | 2023 | 78 | 0.060 |
Why?
|
| Warfarin | 2 | 2023 | 1482 | 0.060 |
Why?
|
| Atenolol | 1 | 2023 | 99 | 0.050 |
Why?
|
| Fluconazole | 1 | 2023 | 156 | 0.050 |
Why?
|
| Registries | 1 | 2019 | 8246 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 3753 | 0.050 |
Why?
|
| Birth Certificates | 1 | 2022 | 71 | 0.050 |
Why?
|
| Adolescent | 5 | 2024 | 88300 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26072 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 5114 | 0.050 |
Why?
|
| Child | 4 | 2024 | 80154 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2023 | 2923 | 0.050 |
Why?
|
| Middle Aged | 6 | 2024 | 220858 | 0.050 |
Why?
|
| Pregnancy Rate | 1 | 2024 | 648 | 0.050 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2022 | 463 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2024 | 513 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 41496 | 0.040 |
Why?
|
| Stroke | 1 | 2020 | 9721 | 0.040 |
Why?
|
| Gadolinium | 1 | 2022 | 961 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 1504 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2024 | 1124 | 0.040 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2016 | 43 | 0.030 |
Why?
|
| Bordetella pertussis | 1 | 2016 | 45 | 0.030 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2016 | 53 | 0.030 |
Why?
|
| Legionella pneumophila | 1 | 2016 | 48 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2019 | 915 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2024 | 1141 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2022 | 845 | 0.030 |
Why?
|
| Fetus | 1 | 2022 | 1864 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 54437 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2024 | 1910 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58952 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 169292 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2022 | 26200 | 0.030 |
Why?
|
| Algorithms | 2 | 2023 | 14025 | 0.020 |
Why?
|
| Migraine Disorders | 1 | 2024 | 1701 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6304 | 0.020 |
Why?
|
| Prevalence | 2 | 2017 | 15721 | 0.020 |
Why?
|
| Contrast Media | 1 | 2022 | 5311 | 0.020 |
Why?
|
| Male | 4 | 2020 | 360703 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2024 | 8479 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5493 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10088 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2019 | 5295 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2020 | 4795 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13249 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15841 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 10707 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29688 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 64681 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 36415 | 0.010 |
Why?
|
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_